| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Academics are from Mars, humanitarians are from Venus: Finding common ground to improve research during humanitarian emergencies
|
Levine, Adam C
|
|
2016
|
13 |
1 |
p. 79-82
|
article
|
| 2 |
A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response
|
Berry, Scott M
|
|
2016
|
13 |
1 |
p. 22-30
|
article
|
| 3 |
A US Food and Drug Administration perspective on evaluating medical products for Ebola
|
Russek-Cohen, Estelle
|
|
2016
|
13 |
1 |
p. 105-109
|
article
|
| 4 |
A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola
|
Cavaleri, Marco
|
|
2016
|
13 |
1 |
p. 101-104
|
article
|
| 5 |
Clinical research during the Ebola virus disease outbreak in Guinea: Lessons learned and ways forward
|
Beavogui, Abdoul Habib
|
|
2016
|
13 |
1 |
p. 73-78
|
article
|
| 6 |
Clinical trials during the Ebola crisis
|
Dodd, Lori E
|
|
2016
|
13 |
1 |
p. 5
|
article
|
| 7 |
Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation
|
Schieffelin, John
|
|
2016
|
13 |
1 |
p. 66-72
|
article
|
| 8 |
Conducting clinical trials in outbreak settings: Points to consider
|
Lane, H Clifford
|
|
2016
|
13 |
1 |
p. 92-95
|
article
|
| 9 |
Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014–2015 outbreak
|
Edwards, Tansy
|
|
2016
|
13 |
1 |
p. 13-21
|
article
|
| 10 |
Ebola clinical trials: Five lessons learned and a way forward
|
Thielman, Nathan M
|
|
2016
|
13 |
1 |
p. 83-86
|
article
|
| 11 |
Ethical challenges to responding to the Ebola epidemic: the World Health Organization experience
|
Saxena, Abha
|
|
2016
|
13 |
1 |
p. 96-100
|
article
|
| 12 |
Evaluating interventions for Ebola: The need for randomized trials
|
Fleming, Thomas R
|
|
2016
|
13 |
1 |
p. 6-9
|
article
|
| 13 |
Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges
|
Kennedy, Stephen B
|
|
2016
|
13 |
1 |
p. 49-56
|
article
|
| 14 |
2015 Peer Reviewers
|
|
|
2016
|
13 |
1 |
p. 110-111
|
article
|
| 15 |
Randomized controlled trials in the West African Ebola virus outbreak
|
Upshur, Ross
|
|
2016
|
13 |
1 |
p. 10-12
|
article
|
| 16 |
Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challenges
|
Vandebosch, An
|
|
2016
|
13 |
1 |
p. 57-65
|
article
|
| 17 |
Statistical considerations for a trial of Ebola virus disease therapeutics
|
Proschan, Michael A
|
|
2016
|
13 |
1 |
p. 39-48
|
article
|
| 18 |
Statistics and logistics: Design of Ebola vaccine trials in West Africa
|
Nason, Martha
|
|
2016
|
13 |
1 |
p. 87-91
|
article
|
| 19 |
Trial design for evaluating novel treatments during an outbreak of an infectious disease
|
Whitehead, John
|
|
2016
|
13 |
1 |
p. 31-38
|
article
|
Journal description